Mesotherapy using autologous platelet-rich plasma in treatment of androgenetic alopecia

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

TCTR

Registry ID

TCTR20180821001

Enrollment

Registered

2018-08-21

Start date

2017-07-28

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Androgenetic alopecia

Interventions

autologous platelet&#45

rich plasma

Experimental Procedure/Surgery

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with androgenetic alopecia

Exclusion criteria

Exclusion criteria: - pregnancy - not willing to follow protocol

Design outcomes

Primary

Measure	Time frame
hair density 0,12,24 weeks trichoscale	—

Secondary

Measure	Time frame
visual hair density 0,12,24 weeks Photograph	—

Countries

Thailand

Contacts

Public ContactRatchathorn Panchaprateep

Faculty of Medicine, Chulalongkorn University

rpanchaprateep@gmail.com0898923819

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026

Mesotherapy using autologous platelet&#45;rich plasma in treatment of androgenetic alopecia